Drug recall · October 8, 2025
Carbamazepine Extended-Release Tablets recall
Why: Failed Dissolution Specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11)
- Lots / codes
Lot #: 1024078, Exp. Date 08/31/2026
- Quantity
- 360 cartons
- Company
- Amerisource Health Services LLC, Columbus, OH
- Distribution
- Nationwide in the USA.
- Initiated
- September 15, 2025 · Voluntary: Firm initiated
- Classified
- September 29, 2025
- Reported
- October 8, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Carbamazepine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.